Application 125277

Type
BLA
Sponsor
DYAX CORP.

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125277Kalbitorecallantide351(a)Rx2026-09-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KALBITORECALLANTIDEINJECTABLE; INJECTION10MG/MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KalbitorECALLANTIDETakeda Pharmaceuticals America, Inc.f56aec67-c662-477c-b866-bfc23e8809cf2025-07-01Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA125277
ndc (product): 47783-101

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47783-101KalbitorEcallantideTakeda Pharmaceuticals America, Inc.BLACurrent
47783-101KALBITORECALLANTIDEDyax Corp.BLACurrent
47783-101KalbitorEcallantideTakeda Pharmaceuticals America, Inc.BLACurrent
47783-101KALBITORECALLANTIDEDyax Corp.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65778SUPPL2020-12-29
65773SUPPL2020-12-28
65772SUPPL2020-12-28
9672SUPPL2014-09-10
39894SUPPL2014-09-09
9671SUPPL2014-04-02
18843SUPPL2014-04-01
9670SUPPL2013-04-16
9669SUPPL2012-04-27
9668SUPPL2011-09-13
9667SUPPL2011-05-17
44796ORIG2010-02-14
43314ORIG2010-02-14
9666ORIG2009-12-08
39893ORIG2009-12-02
23459ORIG2009-12-02